Prodrome Sciences to present new multi-analyte, high-resolution/accurate-mass technology

July 20, 2018

Prodrome Sciences to present new multi-analyte, high-resolution/accurate-mass technology at the Japanese Society for Biomedical Mass Spectrometry Annual Meeting

Dr. Dayan Goodenowe, Prodrome Sciences’ Founder and CEO, will present the validation study results of Prodrome Sciences’ new multi-analyte, high-resolution/accurate-mass technology for the quantification of over 1000 acidic lipid species in human serum at the 43rd Annual Meeting of the Japanese Society for Biomedical Mass Spectrometry on September 6, 2018, in Sapporo, Japan.

Diseases such as colorectal cancer, pancreatic cancer, ovarian cancer, multiple sclerosis, Parkinson’s disease, and dementia are associated with abnormal blood levels of acidic lipids such as fatty acids (EPA, DHA), ultra-long chain fatty acids (GTA-446, PC-594), plasmalogens, phosphatidylethanolamines, and phosphatidylserines. Prodrome Sciences has developed and validated a simple, high-throughput, reproducible method for detecting and quantifying key acidic lipids in human serum.

The simplicity and robustness of Prodrome Sciences’ new technology makes comprehensive metabolomic analyses of large patient populations economically viable. Multiple databases can be easily created and analyzed, and new biomarkers can be discovered for detecting disease and disease risk.

Please contact us for more information.

About Prodrome Sciences Inc.

Prodrome Sciences researches prodromes of diseases – how to detect them, what causes them, and how to return high-risk prodrome states back to a healthy state before the disease develops. We use our advanced diagnostic technology for blood tests to detect disease prodromes and in our natural therapeutic programs to restore an unhealthy, high-risk prodrome state to a healthy, low-risk state. Our goal is to reduce the number of people that develop and die from disease and to promote optimal health.

Keep in touch

©2018 Prodrome Sciences Inc.

Search